A comprehensive view of biontech se. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer/BioNTech ship 1.2 million COVID-19 vaccines to Mexico to immunize children from 5- to 11-years old as part of agreement signed under Covax mechanism; vaccines transferred to Mexico’s National Cancer Institute for cold storage

President Biden’s statement that the COVID-19 pandemic is over results in shares of Moderna, BioNTech, Novavax falling as much as 9% in early trading Monday; COVID-19 vaccine market may start to resemble flu vaccine market valued at US$5.0B annually

FDA approves updated bivalent COVID-19 booster doses from Moderna and Pfizer/BioNTech; Moderna’s shot approved for adults, Pfizer shot approved for people 12 years old and older

Politico reports FDA may authorize Moderna’s and Pfizer-BioNTech’s omicron-adapted boosters as early as Wednesday; federal government to deploy 175 million doses of the boosters shortly after Labor Day

Moderna files patent infringement lawsuits against Pfizer and BioNTech in the US and in Germany; complaint alleges Pfizer and BioNTech's COVID-19 vaccine Comirnaty infringes on mRNA technology patents filed by Moderna between 2010 and 2016

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count